Effects of varying the expression level of recombinant human mGlu1α receptors on the pharmacological properties of agonists and antagonists
- 1 February 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (4) , 873-882
- https://doi.org/10.1038/sj.bjp.0702359
Abstract
1. Different expression levels of the human type 1alpha metabotropic glutamate (mGlu1alpha) receptor were obtained in transfected Chinese hamster ovary cells using an isopropyl beta-D-thiogalactopyranoside (IPTG) inducible system. Expression of mGlu1alpha receptors could not be detected using immunoblotting or immunocytochemical approaches in non-induced cells, however, controlled expression could be induced following IPTG addition in a time- and concentration-dependent manner. 2. In induced cells (100 microM IPTG, 20 h) the agonists L-quisqualate or 1-aminocyclopentane-1S,3R-dicarboxylic acid stimulated large increases in [3H]-inositol (poly)phosphate (in the presence of Li+) and inositol, 1,4,5-trisphosphate levels. 3. Induction with 1-100 microM IPTG allowed the receptor density to be increased incrementally and this not only resulted in an increase in the maximum response to L-quisqualate, 1-aminocyclopentane-1S,3R-dicarboxylic acid and (S)-3,5-dihydroxy-phenylglycine, but also in an increase in the respective potencies of each agent to activate phosphoinositide hydrolysis. 4. The intrinsic activity of the partial agonist 1-aminocyclopentane-1S,3R-dicarboxylic acid dramatically increased with increasing receptor expression. 5. The activities of the competitive mGlu1alpha receptor antagonists (S)-alpha-methyl-4-carboxyphenylglycine and (S)-4-carboxy-3-hydroxyphenylglycine for inhibition of the effects of L-quisqualate or (S)-3,5-dihydroxyphenylglycine were found to be independent of the receptor expression level. 6. When the mGlu1alpha receptor was expressed at very high levels, no evidence for receptor constitutive activity could be detected, and none of the antagonists tested revealed either any intrinsic activity or negative efficacy. 7. These data demonstrate that both the potency and efficacy of mGlu1alpha receptor agonists are influenced by expression level, whilst mGlu1alpha receptor antagonist activities are independent of expression level.Keywords
This publication has 34 references indexed in Scilit:
- Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responsesPublished by Elsevier ,2000
- A modulatory effect of extracellular Ca2+ on type 1α metabotropic glutamate receptor-mediated signallingNeuropharmacology, 1998
- (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptorsBioorganic & Medicinal Chemistry Letters, 1997
- Pharmacological characterization of type 1α metabotropic glutamate receptor‐stimulated [35S]‐GTPγS bindingBritish Journal of Pharmacology, 1997
- Inducible expression of α1B-adrenoceptors in DDT1 MF-2 cells: comparison of receptor density and responseEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- The metabotropic glutamate receptors: Structure and functionsNeuropharmacology, 1995
- Is the heterologous expression of metabotropic glutamate receptors (mGluRs) an appropriate method to study the mGluR function? Experience with human embryonic kidney 293 cells transfected with mGluR1Neurochemistry International, 1994
- Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor familyEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Partial agonists, full agonists, antagonists: dilemmas of definitionTrends in Pharmacological Sciences, 1993